Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Year Ending February 28, 2021
July 09, 2020 at 02:00 am
Share
Hisamitsu Pharmaceutical Co., Inc. provided consolidated earnings guidance for the year ending February 28, 2021. For the year, the company expects to report net sales of JPY 127,000 million, operating profit of JPY 12,900 million, ordinary profit of JPY 14,800 million, and profit attributable to owners of parent of JPY 10,600 million or JPY 129.80 per share.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
HISAMITSU PHARMACEUTICAL CO., INC. 
